Companies/Devonian Health Group Inc.

Company profile

Devonian Health Group Inc.

OTC: DVHGF · Healthcare · Biotechnology

Canadian filerHQ Québec, QCReports USD

#606 of 1,394 Healthcare companies by revenue33rd-percentile growth

EA Score

46D

FH 48DQ —GM 47SS 28

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, operating margin · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

$1.9M

Rev growth YoY (TTM)

-91.5%

Net income (FY)

-$3.1M

Employees

Market cap

$19.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$12.2M17.0M CAD2025

Net income-$3.1M-4.3M CAD2025

Operating income-$736.4k-1.0M CAD2025

Total assets$8.3M11.4M CAD2025

Liabilities$4.8M6.7M CAD2025

Equity$4.8M6.6M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$2.5M

FY18

$3.0M

FY19

$1.6M

FY20

$1.2M

FY21

$1.8M

FY22

$1.7M

FY23

$13.1M

FY24

$12.2M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Devonian Health Group Inc. booked $12.2M in FY2025 revenue, contracting 6.9% year over year — slower than 67% of Healthcare companies we track, at a -25.5% net margin.

Peers · Healthcare

Mountain Valley MD Holdings Inc.——IRIDEX Corporation55C Caring Brands, Inc.20D Dare Bioscience, Inc.37D

Key facts

CEOAndre Boulet

SectorHealthcare

IndustryBiotechnology

HeadquartersQuébec, QC

ExchangeOTC: DVHGF

Employees6

IPO date2022-09-19

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.